Rare Variant Association Testing by Adaptive Combination of P-values

With the development of next-generation sequencing technology, there is a great demand for powerful statistical methods to detect rare variants (minor allele frequencies (MAFs)<1%) associated with diseases. Testing for each variant site individually is known to be underpowered, and therefore many methods have been proposed to test for the association of a group of variants with phenotypes, by pooling signals of the variants in a chromosomal region. However, this pooling strategy inevitably leads to the inclusion of a large proportion of neutral variants, which may compromise the power of association tests. To address this issue, we extend the -MidP method (Cheung et al., 2012, Genet Epidemiol 36: 675–685) and propose an approach (named ‘adaptive combination of P-values for rare variant association testing’, abbreviated as ‘ADA’) that adaptively combines per-site P-values with the weights based on MAFs. Before combining P-values, we first imposed a truncation threshold upon the per-site P-values, to guard against the noise caused by the inclusion of neutral variants. This ADA method is shown to outperform popular burden tests and non-burden tests under many scenarios. ADA is recommended for next-generation sequencing data analysis where many neutral variants may be included in a functional region.

[1]  D. Goldstein,et al.  Uncovering the roles of rare variants in common disease through whole-genome sequencing , 2010, Nature Reviews Genetics.

[2]  Shamil R Sunyaev,et al.  Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.

[3]  Eric Boerwinkle,et al.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL , 2007, Nature Genetics.

[4]  R. Fisher.  On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .

[5]  Wei Pan,et al.  Comparison of statistical tests for disease association with rare variants , 2011, Genetic epidemiology.

[6]  R. Fisher,et al.  Statistical Methods for Research Workers , 1930, Nature.

[7]  Jonathan C. Cohen,et al.  Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.

[8]  P. Rosenberg,et al.  Pathway analysis by adaptive combination of P‐values , 2009, Genetic epidemiology.

[9]  Yun Li,et al.  To identify associations with rare variants, just WHaIT: Weighted haplotype and imputation-based tests. , 2010, American journal of human genetics.

[10]  Xihong Lin,et al.  Optimal tests for rare variant effects in sequencing association studies. , 2012, Biostatistics.

[11]  Hsin-Chou Yang,et al.  Region-based and pathway-based QTL mapping using a p-value combination method , 2010, BMC proceedings.

[12]  Nengjun Yi,et al.  Haplotype Kernel Association Test as a Powerful Method to Identify Chromosomal Regions Harboring Uncommon Causal Variants , 2013, Genetic epidemiology.

[13]  Richard R. Hudson,et al.  Generating samples under a Wright-Fisher neutral model of genetic variation , 2002, Bioinform..

[14]  V. Bansal,et al.  Statistical analysis strategies for association studies involving rare variants , 2010, Nature Reviews Genetics.

[15]  Kathryn Roeder,et al.  Testing for an Unusual Distribution of Rare Variants , 2011, PLoS genetics.

[16]  Ronald M Peshock,et al.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. , 2004, The American journal of cardiology.

[17]  Iuliana Ionita-Laza,et al.  A New Testing Strategy to Identify Rare Variants with Either Risk or Protective Effect on Disease , 2011, PLoS genetics.

[18]  S. Gabriel,et al.  Calibrating a coalescent simulation of human genome sequence variation. , 2005, Genome research.

[19]  Anthony R. Dallosso,et al.  Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. , 2008, Cancer research.

[20]  Dan-Yu Lin,et al.  A general framework for detecting disease associations with rare variants in sequencing studies. , 2011, American journal of human genetics.

[21]  E. Zeggini,et al.  An Evaluation of Statistical Approaches to Rare Variant Analysis in Genetic Association Studies , 2009, Genetic epidemiology.

[22]  Nengjun Yi,et al.  Haplotype‐Based Methods for Detecting Uncommon Causal Variants With Common SNPs , 2012, Genetic epidemiology.

[23]  S. Leal,et al.  Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.

[24]  R. Davies.  The distribution of a linear combination of 2 random variables , 1980 .

[25]  Nengjun Yi,et al.  Evaluation of pooled association tests for rare variant identification , 2011, BMC proceedings.

[26]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[27]  M. Spitz,et al.  Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. , 2008, American journal of human genetics.

[28]  Adam Kiezun,et al.  Exome sequencing and the genetic basis of complex traits , 2012, Nature Genetics.

[29]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[30]  Eric Boerwinkle,et al.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. , 2008, The Journal of clinical investigation.

[31]  R. Fisher.  On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2018, Journal of the Royal Statistical Society Series A (Statistics in Society).

[32]  Shamil R Sunyaev,et al.  Pooled association tests for rare variants in exon-resequencing studies. , 2010, American journal of human genetics.

[33]  N. Norton,et al.  Coding Sequence Rare Variants Identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 From 312 Patients With Familial or Idiopathic Dilated Cardiomyopathy , 2010, Circulation. Cardiovascular genetics.

[34]  Suzanne M. Leal,et al.  A Novel Adaptive Method for the Analysis of Next-Generation Sequencing Data to Detect Complex Trait Associations with Rare Variants Due to Gene Main Effects and Interactions , 2010, PLoS genetics.

[35]  Shuang Wang,et al.  A Fast and Noise‐Resilient Approach to Detect Rare‐Variant Associations With Deep Sequencing Data for Complex Disorders , 2012, Genetic epidemiology.

[36]  Wei Pan,et al.  A Data-Adaptive Sum Test for Disease Association with Multiple Common or Rare Variants , 2010, Human Heredity.

[37]  S. Browning,et al.  A Groupwise Association Test for Rare Mutations Using a Weighted Sum Statistic , 2009, PLoS genetics.

[38]  J. Pritchard.  Are rare variants responsible for susceptibility to complex diseases? , 2001, American journal of human genetics.

[39]  Greg Gibson,et al.  Rare and common variants: twenty arguments , 2012, Nature Reviews Genetics.

[40]  B S Weir,et al.  Truncated product method for combining P‐values , 2002, Genetic epidemiology.

[41]  M. Daly,et al.  Genetic Mapping in Human Disease , 2008, Science.

[42]  David B. Goldstein,et al.  Rare Variants Create Synthetic Genome-Wide Associations , 2010, PLoS biology.

[43]  Nengjun Yi,et al.  Bayesian analysis of rare variants in genetic association studies , 2011, Genetic epidemiology.

[44]  M. Kendall.  Statistical Methods for Research Workers , 1937, Nature.

[45]  W. Bodmer,et al.  Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.